193 related articles for article (PubMed ID: 6751184)
21. [Cimetidine; new hope for ulcer patients?].
Festen HP; Lamersen CB; van Tongeren JH
Ned Tijdschr Geneeskd; 1978 Jun; 122(24):866-70. PubMed ID: 351434
[No Abstract] [Full Text] [Related]
22. [Cimetidine].
Jedrzejewski R
Pol Tyg Lek; 1980 Feb; 35(5):181-4. PubMed ID: 6990390
[No Abstract] [Full Text] [Related]
23. Cimetidine: clinical uses and possible side effects.
Babb RR
Postgrad Med; 1980 Dec; 68(6):87-93. PubMed ID: 6968898
[TBL] [Abstract][Full Text] [Related]
24. An aggressive approach to the medical management of peptic ulcer disease.
Fleshler B; Achkar E
Arch Intern Med; 1981 Jun; 141(7):848-51. PubMed ID: 7235803
[TBL] [Abstract][Full Text] [Related]
25. Cimetidine in clinical use. A review.
Festen HP; Lamers CB; van Tongeren JH
Neth J Med; 1980; 23(5):210-7. PubMed ID: 6999368
[No Abstract] [Full Text] [Related]
26. Ranitidine: a new H2-receptor antagonist.
Berner BD; Conner CS; Sawyer DR; Siepler JK
Clin Pharm; 1982; 1(6):499-509. PubMed ID: 6309467
[TBL] [Abstract][Full Text] [Related]
27. Histamine H2-receptor antagonists.
Feldman M; Richardson CT
Adv Intern Med; 1978; 23():1-24. PubMed ID: 24327
[TBL] [Abstract][Full Text] [Related]
28. [Strong inhibition of gastric acid secretion: when is it justifiable?].
Dobrilla G; Amplaz S; Benvenuti S; Bertozzo A
G Clin Med; 1990; 71(8-9):521-6. PubMed ID: 1980653
[No Abstract] [Full Text] [Related]
29. Cimetidine in elderly patients: review of uses and risks.
Jenike MA
J Am Geriatr Soc; 1982 Mar; 30(3):170-3. PubMed ID: 7037913
[TBL] [Abstract][Full Text] [Related]
30. Pharmacology and clinical efficacy of ranitidine, a new H2-receptor antagonist.
Helman CA; Tim LO
Pharmacotherapy; 1983; 3(4):185-92. PubMed ID: 6136952
[TBL] [Abstract][Full Text] [Related]
31. Omeprazole and acid peptic disease.
Piper DW; Yeomans ND; Shearman DJ
Med J Aust; 1991 Mar; 154(6):374-5. PubMed ID: 2000048
[No Abstract] [Full Text] [Related]
32. Ranitidine.
Strum WB
JAMA; 1983 Oct; 250(14):1894-6. PubMed ID: 6312110
[TBL] [Abstract][Full Text] [Related]
33. [Cimetidine. Clinical pharmacology and toxicity (author's transl)].
Delchier JC; Soule JC; Bader JP
Nouv Presse Med; 1978 May; 7(20):1735-9. PubMed ID: 353705
[TBL] [Abstract][Full Text] [Related]
34. Omeprazole.
Walan A
Baillieres Clin Gastroenterol; 1988 Jul; 2(3):629-40. PubMed ID: 3048454
[No Abstract] [Full Text] [Related]
35. Cimetidine and ulcers.
Misiewicz JJ; Burland WL
Br Med J; 1976 Dec; 2(6049):1445. PubMed ID: 12853
[No Abstract] [Full Text] [Related]
36. Omeprazole: a comprehensive review.
Massoomi F; Savage J; Destache CJ
Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967
[TBL] [Abstract][Full Text] [Related]
37. The use and abuse of histamine H2-receptor antagonists.
Milton-Thompson GJ
J R Nav Med Serv; 1977; 63(1):9-14. PubMed ID: 17005
[No Abstract] [Full Text] [Related]
38. Has cimetidine revolutionised the medical treatment of peptic ulceration?
Pounder RE
J Hum Nutr; 1979 Oct; 33(5):367-70. PubMed ID: 501076
[TBL] [Abstract][Full Text] [Related]
39. [Cimetidine].
Castro Lde P; Salgado JA
AMB Rev Assoc Med Bras; 1981 Oct; 27(10):301-4. PubMed ID: 7045988
[No Abstract] [Full Text] [Related]
40. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
Clissold SP; Campoli-Richards DM
Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
